Another gene found by genome-wide association studies to be a risk factor for NAFLD, is the trans-membrane 6 superfamily member 2 (TM6SF2), non-synonymous variant rs58542926 (49). This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.